Table 1.
β-blockers | Study | Type of study | Effect |
---|---|---|---|
Timolol | Wang et al. (2000) [19] | In vitro | 0.025% to 0.00025% timolol induced cAMP concentration increase in cultured porcine CECs |
Timolol | Wu et al. (2006) [21] | In vitro | 58 μM and 5.8 μM timolol for 200 s increased intracellular Ca2+ concentration in cultured bovine CECs |
Timolol | Izzotti et al. (2008) [25] | In vitro | Pre-treatment with 0.5 mg timolol/ml complete medium/well for 20 h demonstrated protective activity of timolol against oxidative stress induced by exposure to iron/ ascorbic acid in cultured HCECs |
Betaxolol | Wang et al. (2000) [19] | In vitro | 0.05% to 0.0005% betaxolol induced cAMP concentration increase in cultured porcine CECs |
Betaxolol | Wu et al. (2006) [21] | In vitro | 162 μM, 16.2 μM, and 1.62 μM betaxolol for 200 s increased intracellular Ca2+ concentration in cultured bovine CECs |
Carteolol | Wu et al. (2006) [21] | In vitro | 680 μM and 68 μM carteolol for 200 s increased intracellular Ca2+ concentration in cultured bovine CECs |
Levobunolol | Wang et al. (2000) [19] | In vitro | 0.05% to 0.0005% levobunolol induced cAMP concentration increase in cultured porcine CECs |
Levobunolol | Wu et al. (2006) [21] | In vitro | 171 μM, 17.1 μM, and 1.71 μM levobunolol for 200 s increased intracellular Ca2+ concentration in cultured bovine CECs |
Propanolol | Wang et al. (2000) [19] | In vitro | 10–5 M propanolol causes intracellular calcium increase in cultured porcine CECs |
CECs corneal endothelial cells, HCECs human corneal endothelial cells, Ca2+ intracellular calcium, cAMP cyclic adenosine monophosphate